U.S. Physical Therapy, Inc.
USPH
$77.04
-$0.31-0.40%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.12% | 8.90% | 7.64% | 7.53% | 7.75% |
| Total Other Revenue | 26.38% | 22.77% | 17.99% | 10.87% | 5.21% |
| Total Revenue | 14.31% | 10.99% | 9.20% | 8.04% | 7.35% |
| Cost of Revenue | 15.14% | 11.44% | 6.08% | 5.29% | 4.40% |
| Gross Profit | 11.47% | 9.49% | 21.43% | 18.73% | 18.72% |
| SG&A Expenses | 15.85% | 12.20% | 13.29% | 8.96% | 7.78% |
| Depreciation & Amortization | 24.13% | 45.31% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.53% | 12.47% | 10.43% | 9.36% | 8.53% |
| Operating Income | 4.49% | -0.23% | -0.02% | -1.87% | -1.23% |
| Income Before Tax | 26.23% | 21.94% | -21.99% | -15.99% | -8.72% |
| Income Tax Expenses | 24.37% | 20.18% | -14.95% | -3.86% | 5.94% |
| Earnings from Continuing Operations | 26.84% | 22.51% | -24.00% | -19.32% | -12.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -66.07% | -57.84% | 23.08% | 26.50% | 29.36% |
| Net Income | 15.25% | 11.28% | -24.36% | -16.50% | -6.16% |
| EBIT | 4.49% | -0.23% | -0.02% | -1.87% | -1.23% |
| EBITDA | 8.99% | 3.31% | 2.04% | 0.44% | 0.56% |
| EPS Basic | 76.87% | 37.38% | -45.36% | -45.27% | -43.16% |
| Normalized Basic EPS | -23.23% | -21.87% | 17.60% | 15.79% | 15.52% |
| EPS Diluted | 76.87% | 37.38% | -45.25% | -45.17% | -43.07% |
| Normalized Diluted EPS | -23.23% | -21.87% | 17.60% | 15.79% | 15.52% |
| Average Basic Shares Outstanding | 2.83% | 6.23% | 9.90% | 13.87% | 12.85% |
| Average Diluted Shares Outstanding | 2.83% | 6.23% | 9.90% | 13.87% | 12.85% |
| Dividend Per Share | 2.31% | 2.33% | 2.94% | 3.57% | 4.22% |
| Payout Ratio | -0.05% | -0.01% | 0.51% | 0.43% | 0.21% |